CHOSA (CHOSA) | Spotlight

Chosa Oncology, Danish -Swedish biotechnology company, has developed the iCIP platform, which includes a liposomal formulation of cisplatin (LiPlaCis) and the companion diagnostic (DRP) tool detecting patients who benefits the most of the cisplatin treatment. The recently achieved clinical phase 2b results mean that the Company is now gearing up the business development activities to find partners for partnership or trade deal.

Quotes for CHOSA Oncology AB

Right Now

+/-: 0.102
%: 14,61%
Latest: 0.8
High: 0.8
Low: 0.67
Volume: 7 916
Turnover (SEK): 5 490
Market Value (MSEK): 56,8
Time (Latest trade): 2025-01-08 16:48

Board

CEO

Peter Buhl

Chairperson of the Board

Ingrid Atteryd Heiman

Board

Claus Frisenberg Pedersen
Fred Hirsch
Morten Myrhøj
Neil Goldsmith
Ulla Hald Buhl

Articles of association

News

2024-11-11 08:30:00 CHOSA Oncology AB presenterar kvartalsrapport 3 2024
2024-10-23 16:19:19 Spotlight: Kommuniké från extra bolagsstämma den 23 oktober 2024 i Chosa Oncology AB
2024-10-23 16:19:19 Spotlight: Bulletin from the extraordinary general meeting on 23 October 2024 in Chosa Oncology AB
2024-10-04 11:30:00 Kallelse till extra bolagsstämma i Chosa Oncology AB
2024-10-04 11:30:00 Notice of extraordinary general meeting in Chosa Oncology AB

News agencies

2024-11-11 08:37:11 Finwire: Chosa Oncology ökar förlusten
2024-08-30 08:58:20 Finwire: Chosa Oncology minskar förlusten
2024-05-31 08:16:34 Finwire: Chosa Oncology minskar förlusten
2024-04-30 10:19:07 Finwire: Chosa Oncology föreslår nyval av Ingrid Atteryd Heiman som ordförande
2024-04-03 18:31:30 MarketWire: CHOSA has carried out a directed issue of SEK 5,58 million to fund KOL-initiated DRP validation studies and to increase business development activities

Analysis

Largest Owners

Name	Capital %	Votes %	Date
Buhl Krone Holding ApS	22,00	22,00	2024-09-26
Claus Frisenberg Pedersen	11,68	11,68	2023-01-18
IPO Nordic Fund A/S	8,36	8,36	2024-09-26
Smerud Medical Research International AS	7,48	7,48	2024-09-26
Rutger Arnhult	5,48	5,48	2024-09-26
Nels Holding Aps	3,99	3,99	2024-09-26
Lh\|Lh Invest Aps	2,97	2,97	2024-09-26
Karsgaard Holding Ostervra Aps	2,36	2,36	2024-09-26
Sorgenfri Nr. 1 A/S	2,17	2,17	2024-09-26
Rq Solutions Aps	1,87	1,87	2024-09-26

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

CHOSA Oncology AB